These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30909080)

  • 21. P4HA2 promotes proliferation, invasion, and metastasis through regulation of the PI3K/AKT signaling pathway in oral squamous cell carcinoma.
    Chi Z; Wang Q; Wang X; Li D; Tong L; Shi Y; Yang F; Guo Q; Zheng J; Chen Z
    Sci Rep; 2024 Jul; 14(1):15023. PubMed ID: 38951593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K/Akt signaling pathway.
    Ren X; Luo W
    Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):61-64. PubMed ID: 30782296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
    Mukudai Y; Kondo S; Fujita A; Yoshihama Y; Shirota T; Shintani S
    Cell Oncol (Dordr); 2013 Jun; 36(3):233-45. PubMed ID: 23529586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
    Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
    Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
    Sun S; Cui Z; Yan T; Wu J; Liu Z
    Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic eIF6 promotes OSCC malignant behavior through AKT pathway.
    Zhao Z; Chu W; Zheng Y; Wang C; Yang Y; Xu T; Yang X; Zhang W; Ding X; Li G; Zhang H; Zhou J; Ye J; Wu H; Song X; Wu Y
    Cell Commun Signal; 2021 Dec; 19(1):121. PubMed ID: 34922580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antitumor effects of herbal medicine Triphala on oral cancer by inactivating PI3K/Akt signaling pathway: based on the network pharmacology, molecular docking, in vitro and in vivo experimental validation.
    Hu S; Li S; Xu Y; Huang X; Mai Z; Chen Y; Xiao H; Ning W; Gaus S; Savkovic V; Lethaus B; Zimmerer R; Acharya A; Ziebolz D; Schmalz G; Huang S; Zhao J; Hu X
    Phytomedicine; 2024 Jun; 128():155488. PubMed ID: 38493718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overproduced CPSF4 Promotes Cell Proliferation and Invasion via PI3K-AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
    Zhang M; Lin H; Ge X; Xu Y
    J Oral Maxillofac Surg; 2021 May; 79(5):1177.e1-1177.e14. PubMed ID: 33535057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
    Li P; Xiao LY; Tan H
    Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma.
    Zhu L; Shen Y; Sun W
    Biomed Pharmacother; 2017 Jan; 85():712-717. PubMed ID: 27923688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma.
    Ferreira Mendes JM; de Faro Valverde L; Torres Andion Vidal M; Paredes BD; Coelho P; Allahdadi KJ; Coletta RD; Souza BSF; Rocha CAG
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway.
    Wang H; Wang L; Zhou X; Luo X; Liu K; Jiang E; Chen Y; Shao Z; Shang Z
    Biomed Res Int; 2020; 2020():2125656. PubMed ID: 32695810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
    Sun M; Shen Z
    Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Stromal Fibroblast-Induced WNT7A Associated with Cancer Cell Migration Through the AKT/CLDN1 Signaling Axis in Oral Squamous Cell Carcinoma.
    Kayamori K; Katsube KI; Hirai H; Harada H; Ikeda T
    Lab Invest; 2023 Oct; 103(10):100228. PubMed ID: 37541622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.